Pierre Maisonneuve

Plain English
This study looked at how different types of interventions, like diet changes and physical activity, could help overweight or obese breast cancer survivors improve their eating habits over two years. Researchers followed 260 participants and found that those in the diet and activity programs lost more than 5% of their weight and made significant reductions in unhealthy food consumption, particularly sweets and processed meats. Overall, there was a noticeable shift toward healthier eating patterns, especially a Mediterranean diet, which is crucial for long-term health and weight management after cancer. Who this helps: This benefits breast cancer survivors looking to improve their health and manage their weight.

Plain English
This study looked at patients in Italy who had bone metastases from neuroendocrine neoplasms (NENs), focusing on their treatment and survival outcomes. Out of 320 patients, 41% had bone as their first metastatic site, and those with more aggressive cancer characteristics had worse survival rates, with a median overall survival of 62 months. Understanding these factors helps shape treatment plans for these patients and highlight the need for more tailored therapies. Who this helps: This helps patients with neuroendocrine neoplasms and their doctors.

Plain English
This study looked at how a patient's nutritional status affects their ability to receive chemotherapy and their survival rates in advanced pancreatic cancer. Out of 140 patients, 55.7% were at risk of malnutrition, and 33.6% were classified as malnourished. Better nutritional scores were linked to more effective chemotherapy delivery and longer survival, highlighting the need for nutritional assessments to improve treatment outcomes. Who this helps: This helps patients with advanced pancreatic cancer and their healthcare providers.

Plain English
This study looked at the long-term effects of a procedure called endoscopic ultrasound-guided gastroenterostomy (EUS-GE) for patients with cancer, tracking how often symptoms returned and whether any additional treatments were needed over time. The researchers followed 166 patients for about four months and found that symptoms recurred in 11% of cases, but complications were rare, and most patients remained symptom-free after 6 months (96.7%). Additionally, they observed that the stents used in the procedure tended to narrow over time, which could be important for monitoring patients, especially those with benign issues. Who this helps: This helps patients undergoing treatment for cancer and their doctors in managing care and follow-up.

Plain English
The study focused on how obesity affects the progression of intraductal papillary mucinous neoplasms (IPMN), which can lead to pancreatic cancer. Researchers analyzed data from 15 studies involving over 6,000 IPMN patients and found that obese patients were 87% more likely to experience disease progression compared to those with normal weight and were also 148% more likely to develop cancer. This is important because it highlights the need for doctors to consider obesity as a significant risk factor in monitoring and treating patients with IPMN. Who this helps: This helps patients with IPMN and their doctors by emphasizing the importance of managing weight.

Plain English
This study examined how certain breathing exercises can help patients recover faster after lung cancer surgery. Researchers found that patients who used these techniques had a 25% shorter hospital stay compared to those who didn’t. This is important because quicker recovery can lead to better overall health and less strain on healthcare resources. Who this helps: Patients recovering from lung cancer surgery.

Plain English
This study developed a tool to help predict the chances of breast cancer returning in patients who received a specific type of radiation therapy during surgery. It looked at 3,397 patients and found that about 7.8% experienced a recurrence within an average of 6.1 years, with a 5-year return rate of 4.4% and a 10-year rate of 13.5%. Key factors that increased the risk of recurrence included being under 60 years old and having certain tumor characteristics. Who this helps: This tool benefits breast cancer patients and their doctors by providing better guidance on treatment options.

Plain English
This report gathered international experts to create a clear definition and set of guidelines for understanding and diagnosing "fatty pancreas," which refers to excess fat in the pancreas. They agreed that this term should be used for all types of fat buildup and outlined key diagnostic imaging techniques to improve how doctors identify this condition. The report highlights connections between fatty pancreas and issues like type 2 diabetes, pancreatitis, and possibly even pancreatic cancer, while also stressing the need for more high-quality research to support these findings. Who this helps: Patients with pancreatic conditions and their doctors.

Plain English
This study looked at a rare cancer called ampullary adenocarcinoma (AAC) to see if adding chemotherapy after surgery helps patients live longer. It involved 200 patients and found that by better understanding the different subtypes of AAC, doctors could improve treatments. The goal is to determine if chemotherapy tailored to these subtypes makes a difference in survival rates. Who this helps: Patients with ampullary cancer and their doctors.

Plain English
This study looked at how junior endoscopists learn to perform a specific procedure called EUS-guided gastroenterostomy (EUS-GE) using a new technique. Researchers found that after around 30 procedures, junior endoscopists could work independently, and it took between 55 to 70 procedures for them to stabilize their fluoroscopy usage, which is an important measure of efficiency. The technique maintained high success rates (99% technical success and 96% clinical success), showing that even as they learn, junior endoscopists can deliver safe and effective care. Who this helps: This benefits patients needing gastroenterostomy procedures and the junior endoscopists who perform them.

Plain English
This study looked at the link between pancreatic steatosis (a condition where fat builds up in the pancreas) and pancreatic cancer (specifically, pancreatic ductal adenocarcinoma). Researchers found a high prevalence of pancreatic steatosis in cancer patients, reporting that 53.6% of these patients had the condition, and they were over three times more likely to have it than those without cancer. This is important because it highlights the need for consistent ways to diagnose and treat pancreatic steatosis, as it may help in monitoring pancreatic cancer more effectively. Who this helps: This helps patients with pancreatic cancer and their doctors.

Plain English
This study looked at three types of lung tumors called typical carcinoids: oncocytic, spindle cell, and ordinary. Out of 297 cases, 12.1% were oncocytic, 18.5% were spindle cell, and 69.4% were ordinary. It was found that ordinary tumors had a higher risk of death related to cancer, while patients with spindle cell tumors tended to live longer than those with ordinary tumors. Understanding these differences is important for doctors to provide better treatment options and predict outcomes for patients. Who this helps: This information benefits patients and doctors by improving tumor diagnosis and treatment strategies.

Plain English
This study looked at the effects of neoadjuvant chemotherapy on lung cancer patients who had a major surgery called pneumonectomy (removal of a lung) from 2010 to 2024. It found that those who received chemotherapy before surgery had a higher chance of experiencing serious lung-related complications, with a 30-day death rate of 8.19 times higher for these patients compared to those who went straight to surgery. This is important because it highlights the need for careful patient selection and evaluation of lung health before giving chemotherapy to ensure better surgical outcomes. Who this helps: This helps doctors and lung cancer patients make informed treatment decisions.

Plain English
This study examined how well certain measurements of oxygen consumption can predict complications and deaths in lung cancer patients undergoing a major surgery called pneumonectomy. Researchers found that 32.2% of patients experienced complications, while only 2.2% died within 30 days, and 6.7% within 90 days after surgery. Notably, a measurement called ppoVO2max below 10 mL/kg/min was linked to higher rates of complications and mortality, suggesting that using this measure can help identify patients who may be at greater risk. Who this helps: This benefits lung cancer patients and their doctors by improving pre-surgery assessments.

Plain English
This study looked at how certain mutations in the BRAF gene allow cancer cells to grow uncontrollably by escaping their normal regulation. Researchers analyzed the structures of three types of BRAF mutants, including the common V600E mutation, showing that these mutations change the gene's behavior so it remains active when it should be turned off. They found that a drug called PLX8394 could restore the normal function of these mutated BRAF proteins, which is important for developing effective cancer treatments. Who this helps: This helps cancer patients with BRAF mutations.

Plain English
This research studied how common pancreatic exocrine insufficiency (PEI) is in people with celiac disease (CeD). They found that about 13.5% of individuals with diagnosed celiac disease also have PEI, which is similar for both children and adults. Notably, untreated celiac patients have a higher prevalence of PEI at 18.2%, compared to just 6.9% for those on a gluten-free diet. This matters because doctors should check for PEI in celiac disease patients who aren't feeling better on their gluten-free diet. Who this helps: Patients with celiac disease.

Plain English
This study looked at how different inflammatory diseases of the pancreas affect the risk of developing pancreatic cancer. It found that people with hereditary or chronic pancreatitis have the highest risk, while those with acute or autoimmune pancreatitis have a lower risk. Additionally, factors like obesity, diabetes, and antibiotics may also increase this risk. Who this helps: Patients with pancreatic diseases and doctors treating them.

Plain English
This study looked at the long-term results of a surgical technique called robotic-assisted segmentectomy (RAS) for patients with early-stage lung cancer, comparing it to another technique, robotic-assisted lobectomy (RAL). It found that after 10 years, the survival rates were similar, with 90% of patients surviving cancer and only a 1% relapse rate for both methods; however, RAS had a higher chance of the cancer coming back in the same area, with an 11% recurrence rate compared to 2.8% for RAL. This matters because it helps doctors understand the effectiveness of RAS and its potential drawbacks compared to RAL, informing treatment choices for lung cancer patients. Who this helps: Patients with early-stage lung cancer and their doctors.

Plain English
This study looked at patients with lung adenocarcinoma that showed up as ground-glass opacities (GGOs) on CT scans. Out of 172 patients, those with pure GGOs (90 patients or about 52%) were less likely to have aggressive cancer compared to those with partial solid GGOs (82 patients or about 48%). The findings indicate that younger patients and those with earlier-stage cancer had better outcomes, while patients who underwent certain types of surgery faced higher risks of recurrence. Who this helps: This research benefits lung cancer patients and their doctors by providing insights on the best surgical approaches based on tumor characteristics.

Plain English
This study looked at two types of lung cancer, atypical carcinoids (ACs) and large cell neuroendocrine carcinomas (LCNECs), to understand their immune environments. Researchers analyzed tissue samples from 56 ACs and 104 LCNECs and found that LCNECs had much higher levels of immune cells and markers that indicate a stronger immune response compared to ACs. Specifically, while LCNECs showed significant immune activity, no ACs exhibited a certain immune marker (PD-L1), suggesting that these cancers respond differently to treatment, which could guide future therapies. Who this helps: This research benefits patients by informing treatment strategies and helping doctors better understand cancer differences.

Plain English
This study compared two surgical methods, minimally invasive pancreatoduodenectomy (MIPD) and open pancreatoduodenectomy (OPD), for treating certain types of pancreatic tumors. Researchers found that MIPD had slightly fewer overall complications (33.4 vs. 35.3 on a scale where higher scores indicate more complications) and allowed patients to recover faster, returning to normal activities in about 7 days compared to 8 days with OPD. The findings are significant because they indicate that MIPD can be just as safe as the traditional open surgery while improving recovery time, which could lead to better outcomes for patients. Who this helps: This helps patients undergoing surgery for pancreatic tumors.

Plain English
This study looked at a surgical procedure called the pericardio-peritoneal window (PPW) for treating a rare condition where fluid builds up around the heart in cancer patients. Out of 44 patients who had the procedure, 95.5% did not need more treatments for fluid buildup afterward, although there was a 9% chance of dying within 30 days after surgery. This is important because it shows that PPW is a safe and effective option for many patients dealing with this serious complication of cancer. Who this helps: This helps cancer patients experiencing fluid buildup around the heart.

Plain English
This study looked at how a 6-month program promoting healthier eating and more physical activity affected overweight or obese women who have survived breast cancer. Out of 266 participants, 37.5% in the dietary-only group and 36.7% in the combined diet and activity group lost more than 5% of their weight. Those who focused on diet lost an average of 4.7% of their weight, while significant improvements in blood sugar levels were also noted, especially in those doing both diet and physical activity. Who this helps: This benefits breast cancer survivors who are overweight or obese and want to improve their health.

Plain English
This study looked at data from over 2,500 patients with autoimmune hepatitis to identify factors that affect their health outcomes. It found that patients who did not achieve a complete biochemical response to treatment within six months had a significantly higher risk of liver-related death (5.7 times more likely) and needed liver transplants. Other risks included being non-White and having cirrhosis or a specific type of autoimmune condition. Who this helps: This helps patients with autoimmune hepatitis and their doctors understand key factors that affect treatment success and health outcomes.

Plain English
This study looked at the risk of developing liver cancer, known as hepatocellular carcinoma (HCC), in patients with autoimmune hepatitis (AIH). Researchers followed 1,428 patients over an average of 11 years and found that only 24 patients (1.7%) developed HCC. The study revealed that certain factors, such as having cirrhosis, obesity, and a specific syndrome related to AIH, greatly increased the risk of developing cancer, making it important for doctors to monitor these patients closely. Who this helps: Patients with autoimmune hepatitis and their doctors.

Plain English
This study examined how receptor guanylyl cyclase C (GC-C) differs between mice and humans, focusing on how these differences affect drug testing for gastrointestinal diseases. The researchers found that mouse GC-C binds ligands with much lower strength than human GC-C, and requires higher concentrations of these molecules to trigger responses in the mouse gut. This matters because it suggests that using mice in research may not accurately predict how drugs will work in humans, which can lead to ineffective treatments. Who this helps: This helps researchers and drug developers working on therapies for gastrointestinal diseases.

Plain English
This study examined a rare type of lung cancer called large cell carcinoma (LCC) by analyzing 16 patient cases. Researchers found that the gene TP53 was inactivated in 93.7% of the cases, and they discovered two different subtypes of LCC: Pure-LCC and adenocarcinoma-like LCC (ADLike-LCC), each with unique characteristics. Understanding these differences is important because it can lead to more targeted treatments for patients based on the specific subtype of cancer they have. Who this helps: This helps patients with large cell carcinoma and their doctors in making better treatment decisions.

Plain English
This study explored how two specific proteins, CNK and HYP, help activate another protein called RAF, which is important in controlling cell growth and can lead to cancer when not functioning properly. The researchers found that the interaction between KSR and MEK is strengthened, enhancing RAF activation, through a complex structure resembling a ring that stabilizes these proteins together. Understanding this mechanism is important because it reveals new ways that proteins interact and could lead to better insights into how cancer develops. Who this helps: This helps cancer researchers and patients by providing new targets for treatment development.

Plain English
This study looked at 51 patients in Italy with advanced mixed neuroendocrine tumors related to the digestive system and their treatment with chemotherapy. It found that those with a specific tumor marker (Ki67 index less than 55%) lived longer, with a median overall survival of 35.3 months compared to 11.9 months for those with a higher index. On average, patients survived about 14 months, highlighting the complexity of treating these tumors and the need for better treatment strategies. Who this helps: This information benefits doctors and healthcare providers managing patients with advanced gastro-entero-pancreatic MiNENs.

Plain English
This study looked at the effects of a drug called fenretinide in young women at high genetic risk for breast cancer. Researchers found that after one year, women taking fenretinide had lower levels of glucose and insulin, and higher levels of good cholesterol, which are all positive changes related to cancer risk. However, not all changes lasted after three years and not all biomarkers were affected. Who this helps: This benefits young women with a family history or genetic predisposition to breast cancer.

Plain English
This study looked at the long-term outcomes of two types of breast cancer—lobular and ductal—among patients who were considered high-risk. The researchers analyzed data from over 15,000 patients and found that both groups had similar survival rates over time; specifically, 5-year invasive disease-free survival rates were 77.7% for ductal cancer and 75.5% for lobular cancer, while 10-year rates were 57.3% for ductal and 50.7% for lobular. This information is important because it helps doctors understand that, despite being different types of cancer, lobular and ductal cancers can respond similarly to treatment when patients are at high risk. Who this helps: This helps patients with high-risk hormone receptor-positive breast cancer and their doctors in treatment planning.

Plain English
This study examined how the distance of cancer-free tissue around a tumor, known as margin clearance, affects the survival of patients with pancreatic cancer whose disease has spread to nearby lymph nodes. Researchers looked at data from 505 patients and found that having a margin clearance greater than 1 mm did not improve overall survival rates, while receiving additional treatment after surgery (adjuvant therapy) was linked to better survival outcomes for patients at advanced stages of the disease. This matters because it highlights that focusing on margin clearance may not be as important as ensuring patients receive follow-up therapy for better health outcomes. Who this helps: This benefits patients with advanced pancreatic cancer and their doctors.

Plain English
This study looked at 1,000 patients who had robotic surgery to remove part of their lungs because of cancer, over a span of 16 years. The results showed that almost all patients (99.7%) had successful surgeries, with very low rates of death (0% within 30 days) and minor complications in about 21% of patients. This technique has similar cancer control outcomes to traditional surgery and demonstrates that robotic surgery can be performed safely and effectively. Who this helps: This helps lung cancer patients by providing a minimally invasive surgical option with good outcomes.

Plain English
This study looked at patients with a specific type of lung cancer (pN1 non-small cell lung cancer) who had surgery to remove part of their lung (pneumonectomy). The researchers found that whether these patients received extra chemotherapy after surgery or not made little difference in their overall survival rates or cancer-free survival five years later. This matters because it suggests that some patients might not need chemotherapy after surgery, which could help avoid unnecessary treatment and its side effects. Who this helps: Patients who have undergone pneumonectomy for pN1 lung cancer.

Plain English
The WATERLAND trial is studying whether lactated Ringer's solution (LR) is better than normal saline (NS) for treating patients with acute pancreatitis (AP). The researchers will compare the two fluids in 792 patients to see if LR reduces the severity of AP, with a specific focus on whether it can lower the rates of moderately severe or severe cases from an expected 17% in the LR group. The results will help improve treatment strategies for this common condition, which could lead to better patient outcomes. Who this helps: Patients with acute pancreatitis.

Plain English
This study looked at whether using Incentive Respiratory Techniques (IT) helps patients recover better after lung cancer surgery compared to just moving around early after the operation. The research involved 304 patients, but after matching them for age, sex, and weight, 52 patients from each group were analyzed. The findings showed that IT did not significantly reduce issues like oxygen needs or complications, although there were hints that it might lead to shorter hospital stays and faster recovery in some cases. Who this helps: This helps lung cancer patients recovering from surgery.

Plain English
This study looked at genetic changes (mutations) in a gene called CDH1, which is linked to a type of stomach cancer called diffuse gastric cancer. Researchers found that out of 247 genetic changes they reviewed, about 70% of those not linked to cancer were not meeting the necessary medical criteria for testing, while all changes associated with cancer closely followed the updated guidelines. This is important because it means genetic testing for CDH1 should only be done in families that meet specific criteria, ensuring that resources are focused where they are most needed. Who this helps: This helps patients at risk for hereditary diffuse gastric cancer.

Plain English
This study looked at how much university students in Qatar know about the Human Papilloma Virus (HPV) and the HPV vaccine. Out of 398 students surveyed, 22% had poor knowledge of HPV, while 55% had some awareness, and only 6.3% had been vaccinated. However, 71% of those who had not been vaccinated expressed willingness to get the vaccine if their healthcare provider recommended it. Who this helps: This benefits university students by improving their understanding of HPV and increasing vaccination rates.

Plain English
This study focused on improving how researchers predict the structures of PROTACs, which are designed to help remove unwanted proteins from cells. The scientists developed a new way to create accurate models of protein interactions, leading to more reliable predictions about how well these PROTACs will work; specifically, they found that the best models correlated with high accuracy in understanding how quickly conditions for protein degradation occur. This is important because it can enhance the development of new treatments targeting diseases caused by malfunctioning proteins. Who this helps: This benefits researchers developing new drug therapies and ultimately patients with cancer and other diseases linked to abnormal protein regulation.

Plain English
This study looked at how a patient's pre-surgery inflammation levels affect their long-term outcomes after lung cancer surgery. Out of 257 patients, the survival rates were quite high, with 96.1% alive after one year, but those with higher inflammation markers faced worse outcomes. Key findings included that specific inflammation measures, like HALP levels and Thoracoscore, were linked to a higher risk of death. Who this helps: This research benefits lung cancer patients by helping doctors better predict their survival outcomes based on inflammation levels.

Plain English
This study examined a treatment called EUS-guided gastroenterostomy (EUS-GE) for patients with malignant gastric outlet obstruction (mGOO), a condition that blocks the stomach due to cancer. In a group of 70 patients who underwent EUS-GE, the success rate for relieving symptoms was 100%, compared to 75% for a group of patients who received enteral stenting. This matters because EUS-GE not only provided faster and more effective relief from symptoms but also had fewer cases of symptoms returning. Who this helps: This helps patients suffering from malignant gastric outlet obstruction and their doctors looking for effective treatment options.

Plain English
This study looked at various scoring systems used to predict severe acute pancreatitis (SAP) in patients and evaluated their effectiveness. Researchers found that while the pre-test probability of having SAP was between 16.6% to 25.3%, the post-test probabilities after using different scoring systems showed that a positive score increased the likelihood of having SAP to around 40-50%, but a negative score dropped it to just 5-7%. This matters because it highlights that these commonly used scoring systems are not very effective in helping doctors make decisions about a patient's condition. Who this helps: This research helps doctors by providing insights into the limitations of current scoring systems for severe acute pancreatitis.

Plain English
This research study, called the DIPLOMA-2 trial, is comparing two types of surgery for patients with certain pancreas tumors: a new, less invasive method called minimally invasive pancreatoduodenectomy (MIPD) and the traditional open surgery method (OPD). The study involves 288 patients across 14 hospitals in Europe and is looking to see if MIPD leads to fewer complications and faster recovery compared to OPD. The trial aims to show that MIPD can become the preferred method for this type of surgery, which would help patients recover more quickly and comfortably. Who this helps: This helps patients undergoing surgery for pancreatic and peri-ampullary tumors.

Plain English
This study looked at 181 patients with primary sclerosing cholangitis (PSC), a serious liver disease that can lead to liver failure. Researchers found that patients with high levels of a specific type of antibody called IgG4 had significantly more instances of cholangitis (a bile duct infection) and needed procedures called ERCP to treat their condition. This information is important because it suggests that measuring IgG4 levels could help predict which PSC patients may face more complications and need medical intervention sooner. Who this helps: Patients with primary sclerosing cholangitis and their doctors.